Ravuconazole (codenamed BMS-207147 and ER-30346) is a potent triazole antifungal, the development of which was discontinued in 2007.[1] The drug has shown to have a similar spectrum of activity to voriconazole, with an increased half-life.[2] However, ravuconazole has limited activity against species of Fusarium, Scedosporium, and Zygomycetes.[3][4]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEBI |
|
ChEMBL |
|
NIAID ChemDB |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C22H17F2N5OS |
Molar mass | 437.47 g·mol−1 |
3D model (JSmol) |
|
| |
| |
![]() ![]() |